Physician profile
Jason Thomas
NPI 1578276234
$3,266.41
in general payments reported to CMS, 2019-2025
28 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $970 · 2024: $1,261 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,266.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $539.70 | 2023-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $499.92 | 2023-2025 | Brilinta, Wainua, Farxiga |
| Novartis Pharmaceuticals Corporation | $479.11 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $261.91 | 2023-2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $184.35 | 2023-2025 | Onpattro, Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.16 | 2023-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $132.77 | 2023-2024 | Inpefa |
| Amgen INC. | $118.51 | 2023-2025 | Repatha, Repatha |
| United Therapeutics Corporation | $101.25 | 2023-2025 | Tyvaso, Tyvaso |
| Kiniksa Pharmaceuticals, LTD. | $85.65 | 2023 | Arcalyst |
| Boston Scientific Corporation | $75.06 | 2024-2025 | Watchman Flx |
| Actelion Pharmaceuticals US, INC. | $74.25 | 2024-2025 | Opsumit, Uptravi |
| Novo Nordisk INC | $71.10 | 2024-2025 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $70.15 | 2024 | Arcalyst |
| Heartflow, INC. | $53.95 | 2023 | Ffrct |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $42.11 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $40.10 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bridgebio Pharma, INC. | $34.45 | 2025 | Attruby |
| Lilly USA, LLC | $31.96 | 2025 | Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $29.86 | 2024-2025 | Nexletol |
| Angiodynamics, INC. | $24.52 | 2023 | Alphavac |
| Chiesi USA, INC. | $22.93 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $22.39 | 2025 | Camzyos |
| Tactile Systems Technology INC | $19.43 | 2025 | Nimbl, Flexitouch Plus |
| Inari Medical, INC. | $17.97 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cordis US Corp. | $17.31 | 2025 | Mynx Control Venous |
| Pfizer INC. | $16.17 | 2025 | |
| Glaxosmithkline, LLC. | $15.37 | 2025 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.